Mark Cuban: Employers Are Unknowingly Profiting From Sick Workers’ Drug Costs
Mark Cuban warned that many employers are collecting drug rebate money funded by their sick employees — a practice that can violate fiduciary duties under ERISA.
Senators Introduce Bipartisan Bill To Increase Oversight Of PBMs
A bipartisan Senate bill would boost transparency and oversight of pharmacy benefit managers by changing how they’re paid, expanding reporting requirements and strengthening protections for pharmacies and taxpayers.
With ACA Subsidies Set To Expire And The Open Enrollment Window Closing, Members Of Congress Brainstorm Alternatives
What are the alternatives to extending ACA subsidies for the 22 million people who purchase health plans on the ACA Marketplace? That's the focus of the latest episode of the Debunked podcast.
Higher Drug Prices, No Tariffs: U.K. Trade Pact Shows How Trump Is Coaxing Countries To Pay More For Meds
The new trade agreement’s parameters could shape deals the Trump administration is pursuing with other countries.
What Is Needed To Rebuild Trust In U.S. Healthcare?
Americans largely trust their doctors but are skeptical of payers, drugmakers, and hospital leadership.
CVS Health Exec: We Need A Better Definition Of What Good Looks Like In Behavioral Health
Behavioral health needs a clearer definition of quality care, which may require policy action, according to Dr. Taft Parsons of CVS Health.
The Trump Gold Card: A New $1 Million Pathway To A U.S. Green Card
A new proposal would let wealthy foreign nationals secure an opportunity for a U.S. green card with a $1 million 'gift' to the government, sparking legal and ethical debate.
Lawmakers Introduce Multiple Bills Aimed At Medicare Advantage Reform
Thirteen House Democrats introduced eight bills to rein in Medicare Advantage and bolster traditional Medicare.
Healthcare Organizations Slam CDC For Changing Website With Misleading Vaccine Claims
The CDC drew widespread criticism for updating its website with language suggesting a possible link between vaccines and autism, contradicting established science.
Who Will Pay If ACA Tax Credits Lapse?
About 22 million Americans would face sharply higher healthcare costs if enhanced ACA tax credits expire at the end of the year.
Function Health Hits $2.5B Valuation With $298M Series B
Function Health raised a $298 million Series B round, pushing its valuation into unicorn territory at $2.5 billion. The Austin-based startup offers subscribers access to more than 160 lab tests, as well as imaging.
Why Your Practice Is Burning Money And How You Can Do Better
Our expert panel explores common sources of profit leakage along with practical steps for improvement.
Why Shared Savings Still Isn’t A Viable Business Model For Hospitals
Shared savings programs are appealing in theory, but the incentives are too weak and unpredictable to support a scalable business model for hospitals, said Patrick Runnels, chief medical officer of University Hospitals.
The 340B Program’s New Rebate Pilot Won’t Fix Its Problems
As HRSA launches a new rebate-based model meant to boost oversight, experts warned that it could instead burden smaller providers and fail to address the program’s deeper flaws.
Debunked Podcast: The Drug Price Debate, AI In Healthcare Companies Face Consolidation But How Much?
How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are working with the Trump administration to lower costs?
Pfizer Lawsuits Allege Novo Nordisk’s Bid To Buy Obesity Biotech Metsera Is Anticompetitive, Illegal
Metsera called the arguments ‘nonsense’ and said Pfizer is trying to buy the obesity drug developer for less than what Novo is willing to pay.
California Signs PBM Law: As Federal PBM Regulation Lags, The States Step Up
With federal PBM reform stalled, states like California are stepping up with laws like SB 41 to boost transparency and lower drug costs.